Literature DB >> 10927724

Self-reported hypertension treatment practices among primary care physicians: blood pressure thresholds, drug choices, and the role of guidelines and evidence-based medicine.

D J Hyman1, V N Pavlik.   

Abstract

BACKGROUND: Primary care physician treatment practices affect the rate of hypertension control to the goal of 140/90 mm Hg. Awareness of and agreement with national hypertension management guidelines, and grounding in evidence-based medicine principles, may be important determinants of practice.
METHODS: A 26-item mail questionnaire was sent to a national sample of 1200 primary care physicians. The questionnaire elicited (1) the blood pressure (BP) criteria physicians use to initiate and intensify hypertension treatment, (2) first-line drug treatment choices, (3) familiarity with the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC) hypertension treatment guidelines, and (4) familiarity with research methods used to develop evidence-based medicine guidelines. The analysis focused on (1) determining the percentage of physicians who reported treatment practices consistent with JNC recommendations and (2) the relation between familiarity with JNC guidelines, evidence-based medicine methods, and reported treatment practices.
RESULTS: The overall response rate was 34%, with no important differences in demographic or professional training variables between respondents and nonrespondents. For middle-aged patients with uncomplicated hypertension, 33% of physicians would not start drug therapy unless the diastolic BP was greater than 95 mm Hg, and 43% would not start unless the systolic BP was greater than 160 mm Hg. In patients without complications who were receiving drug treatment, 25% of physicians would not intensify therapy for a persistent diastolic BP of 94 mm Hg, and 33% would not intensify therapy for a systolic BP of 158 mm Hg. Physicians were generally less aggressive in older patients. Angiotensin-converting enzyme inhibitors were the most common first-line drug choice. Forty-one percent of physicians had not heard of or were not familiar with the JNC guidelines. In multiple logistic regression models, familiarity with the JNC guidelines was associated with lower treatment thresholds, and increased familiarity with research methods was associated with greater use of diuretics or beta-blockers as first-line agents.
CONCLUSIONS: Many physicians have higher BP thresholds for the diagnosis and treatment of hypertension than the 140/90 mm Hg criterion recommended by the JNC. Therefore, further improvements in population hypertension control will require physician behavior change. Physician practice is associated with awareness of practice guidelines and familiarity with evidence-based medicine methods, but the precise nature and extent of this relation requires further study.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10927724     DOI: 10.1001/archinte.160.15.2281

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  110 in total

1.  Quality measurement as a prerequisite for improving hypertension control in an academic medical center.

Authors:  Fani E Syrrokosta; Konstantinos M Lampropoulos; Ioannis Papargyriou; Dimitrios Papadogiannis
Journal:  Clin Cardiol       Date:  2011-12-07       Impact factor: 2.882

2.  Nurse-led disease management for hypertension control in a diverse urban community: a randomized trial.

Authors:  Paul L Hebert; Jane E Sisk; Leah Tuzzio; Jodi M Casabianca; Velvie A Pogue; Jason J Wang; Yingchun Chen; Christine Cowles; Mary Ann McLaughlin
Journal:  J Gen Intern Med       Date:  2011-12-06       Impact factor: 5.128

Review 3.  Measuring adherence to practice guidelines for the management of hypertension: an evaluation of the literature.

Authors:  Jessica L Milchak; Barry L Carter; Paul A James; Gail Ardery
Journal:  Hypertension       Date:  2004-09-20       Impact factor: 10.190

4.  Disease management to promote blood pressure control among African Americans.

Authors:  Troyen Brennan; Claire Spettell; Victor Villagra; Elizabeth Ofili; Cheryl McMahill-Walraven; Elizabeth J Lowy; Pamela Daniels; Alexander Quarshie; Robert Mayberry
Journal:  Popul Health Manag       Date:  2010-04       Impact factor: 2.459

Review 5.  Treatment of isolated systolic hypertension.

Authors:  Gordon S Stokes
Journal:  Curr Hypertens Rep       Date:  2006-10       Impact factor: 5.369

6.  Systolic blood pressure elevation: it's where the action is.

Authors:  Jan N Basile
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

Review 7.  Olmesartan vs. ramipril in elderly hypertensive patients: review of data from two published randomized, double-blind studies.

Authors:  Stefano Omboni; Ettore Malacco; Jean-Michel Mallion; Paolo Fabrizzi; Massimo Volpe
Journal:  High Blood Press Cardiovasc Prev       Date:  2014-01-17

8.  The Importance of Systolic Blood Pressure Control and Cardiovascular Disease Prevention.

Authors:  Jan N. Basile
Journal:  Curr Treat Options Cardiovasc Med       Date:  2003-08

9.  Barriers to physician adherence to nonsteroidal anti-inflammatory drug guidelines: a qualitative study.

Authors:  J M Cavazos; A D Naik; A Woofter; N S Abraham
Journal:  Aliment Pharmacol Ther       Date:  2008-09-15       Impact factor: 8.171

10.  Prehypertension and hypertension in a primary care practice.

Authors:  Marshall Godwin; Andrea Pike; Allison Kirby; Carolyn Jewer; Laura Murphy
Journal:  Can Fam Physician       Date:  2008-10       Impact factor: 3.275

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.